Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders

For the coming new era of the modern world, accumulating stressors will represent a significant hurdle, likely increasing the prevalence of mood and anxiety disorders. Furthermore, the consequences of the COVID-19 pandemic may further increase these disorders. Thus, we need to investigate potential biomarkers for these disorders, as they could assist us in alleviating the clinical symptoms and preventing the subsequent sequela. Since we know that the brain controls and manipulates psychological status and related behaviors, we should scrutinize the brain's biomarkers of mood and anxiety disorders.